Bronwen Shaw, MD

Trials

Studies that name Bronwen Shaw, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:48 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT05600426 · A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

  Boston Children's Hospital · terminated · Severe Aplastic Anemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 04:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
  UG3HL157564 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Michael A Pulsipher, DAVID A WILLIAMS · fiscal years 2022
  Named on NCT05600426
• 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
  U24HL157560 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Bronwen Shaw · fiscal years 2022 to 2025
  Named on NCT05600426